Taurine administration after appearance of proteinuria retards progression of diabetic nephropathy in rats

Kobe Journal of Medical Sciences

Volumn 54, Issue 1, 2008, Pages 35-45

  Higo, Satomi ^a   Miyata, Satoshi ^a   Qing, Yun Jiang ^a   Kitazawa, Riko ^a   Kitazawa, Sohei ^a   Kasuga, Masato ^a  

^a KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Diabetic nephropathy; Glycation; Oxidative stress; Taurine

Indexed keywords

3 NITROTYROSINE; 8 HYDROXYDEOXYGUANOSINE; PENTOSIDINE; STREPTOZOCIN; TAURINE; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; CELL EXPANSION; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DISEASE COURSE; DRUG INHIBITION; EXTRACELLULAR MATRIX; GLOMERULUS; IMMUNOHISTOCHEMISTRY; MALE; NONHUMAN; OXIDATIVE STRESS; PROTEIN EXPRESSION; PROTEIN SECRETION; PROTEIN URINE LEVEL; PROTEINURIA; RAT; STAINING; URINARY EXCRETION;

ANIMALS; BIOLOGICAL MARKERS; BLOOD GLUCOSE; BODY WEIGHT; DEOXYGUANOSINE; DIABETIC NEPHROPATHIES; DISEASE PROGRESSION; HEMOGLOBIN A, GLYCOSYLATED; IMMUNOHISTOCHEMISTRY; MALE; OXIDATIVE STRESS; PROTEINURIA; RATS; RATS, SPRAGUE-DAWLEY; TAURINE; TYROSINE;

EID: 45849118618     PISSN: 00232513     EISSN: 18830498     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Alvarado-Vasquez, N., Zamudio, P., Ceron, E., Vanda, B., Zenteno, E., and Carvajal-Sandoval, G. 2003. Effect of glycine in streptozotocin-induced diabetic rats. Comp Biochem Physiol C Toxicol Pharmacol. 134: 521-527.
2. Asaba, K., Tojo, A., Onozato, M. L., Goto, A., and Fujita, T. 2007. Double-edged action of SOD mimetic in diabetic nephropathy. 49: 13-19.
3. Bradford, M.M. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72: 248-254.
4. Cruz, C. I., Ruiz-Torres, P., del-Moral, R. G., Rodriguez-Puyol, M., and Rodriguez-Puyol, D. 2000. Age-related progressive renal fibrosis in rats and its prevention with ACE inhibitors and taurine. Am. J. Physiol. 278: F122-129.
5. Davison, A. N., and Kaczmarek, L. K. 1971. Taurine--a possible neurotransmitter? Nature 234: 107-108.
6. Devamanoharan, P. S., Ali, A. H., and Varma, S. D. 1998. Oxidative stress to rat lens in vitro: protection by taurine. Free. Radic. Res. 29: 189-195.
7. Efrati, S., Averbukh, M., Berman, S., Feldman, L., Dishy, V., Kachko, L., Weissgarten, J., Golik, A., and Averbukh, Z. 2005. N-Acetylcysteine ameliorates lithium-induced renal failure in rats. Nephrol. Dial. Transplant. 20: 65-70.
8. Franconi, F., Bennardini, F., Mattana, A., Miceli, M., Ciuti, M., Mian, M., Gironi, A., Anichini, R., and Seghieri, G. 1995. Plasma and platelet taurine are reduced in subjects with insulin-dependent diabetes mellitus: effects of taurine supplementation. Am. J. Clin. Nutr. 61: 1115-1119.
9. Franconi, F., Di Leo, M.A., Bennardini, F., and Ghirlanda, G. 2004. Is taurine beneficial in reducing risk factors for diabetes mellitus? Neurochem Res. 29: 143-150.
10. Franconi, F., Loizzo, A., Giovanni, G., and Seghieri, G. 2006. Taurine supplementation and diabetes mellitus. Curr Opin Clin Nutr Metab Care. 9: 32-36.
11. Franconi, F., Miceli, M., Fazzini, A., Seghieri, G., Caputo, S., DiLeo, M. A., Lepore, D., and Ghirlanda, G. 1996. Taurine and diabetes. Humans and experimental models. Adv. Exp. Med. Biol. 403: 579-582.
12. Ha, H., Kim, C., Chung, M. H., and Kim, K. H. 1994. DNA damage in the kidneys of diabetic rats exhibiting microalbuminuria. Free. Radic. Biol. Med. 16: 271-274.
13. Ha, H., Yu, M. R., and Kim, K. H. 1999. Melatonin and taurine reduce early glomerulopathy in diabetic rats. Free. Radic. Biol. Med. 26: 944-950.
14. Hamada, Y., Miyata, S., Nii-Kono, T., Kitazawa, R., Kitazawa, S., Higo, S., Fukunaga, M., Ueyama, S., Nakamura, H., Yodoi, J., Fukagawa, M., and Kasuga, M. 2007. Overexpression of thioredoxin1 in transgenic mice suppresses development of diabetic nephropathy. Nephrol Dial Transplant. 22: 1547-1557
15. Hansen, S. H. 2001. The role of taurine in diabetes and the development of diabetic complications. Diabetes Metab Res Rev. 17: 330-346.
16. Heidland, A., Sebekova, K., and Schinzel, R. 2001. Advanced glycation end products and the progressive course of renal disease. Am. J. Kidney Dis. 38 :S100-106.
17. Horie, K., Miyata, T., Maeda, K., Miyata, S., Sugiyama, S., Sakai, H., van Ypersele. de Strihou, C., Monner, V. M., Witztum, J. L., and Kurokawa, K. 1997. Immunohistochemical colocalization of glycoxidation products and lipid peroxidation products in diabetic renal glomerular lesions. Implication for glycoxidative stress in the pathogenesis of diabetic nephropathy. J Clin Invest. 100: 2995-3004.
18. Huxtable, R. J. 1992. Physiological actions of taurine. Physiol. Rev. 72: 101-163.
19. Iglesias-de-la-Cruz, M. C., Ruiz-Torres, P., Alcami, J., Diez-Marques, L., Ortega-Velazquez, R., Chen, S., Rodriguez-Puyol, M., Ziyadeh, F. N., and Rodriguez-Puyol, D. 2001. Hydrogen peroxide increases extracellular matrix mRNA through TGF-beta in human mesangial cells. Kidney Int. 59: 87-95.
20. Li, Y. P., and Lombardini, J. B. 1991. Inhibition by taurine of the phosphorylation of specific synaptosomal proteins in the rat cortex: effects of taurine on the stimulation of calcium uptake in mitochondria and inhibition of phosphoinositide turnover. Brain Res. 553: 89-96.
21. Miyazaki, T., Aoyama, I., Ise, M., Seo, H., and Niwa, T. 2000. An oral sorbent reduces overload of indoxyl sulphate and gene expression of TGF-beta1 in uraemic rat kidneys. Nephrol. Dial. Transplant. 15: 1773-1781.
22. Odetti, P., Pesce, C., Traverso, N., Menini, S., Maineri, E.P., Cosso, L., Valentini, S., Patriarca, S., Cottalasso, D., Marinari, U.M., and Pronzato, M.A. 2003. Comparative trial of N-acetyl-cysteine, taurine, and oxerutin on skin and kidney damage in long-term experimental diabetes. Diabetes. 52: 499-505.
23. Okada, S., Shikata, K., Matsuda, M., Ogawa, D., Usui, H., Kido, Y., Nagase, R., Wada, J., Shikata, Y., and Makino, H. 2003. Intercellular adhesion molecule-1-deficient mice are resistant against renal injury after induction of diabetes. Diabetes 52: 2586-2593.
24. Studer, R. K., Craven, P. A., and DeRubertis, F. R. 1997. Antioxidant inhibition of protein kinase C-signaled increases in transforming growth factor-beta in mesangial cells. Metabolism 46: 918-925.
25. Suzuki, D., Miyata, T., Saotome, N., Horie, K., Inagi, R., Yasuda, Y., Uchida, K., Izuhara, Y., Yagame, M., Sakai, H., and Kurokawa, K. 1999. Immunohistochemical evidence for an increased oxidative stress and carbonyl modification of proteins in diabetic glomerular lesions. J. Am. Soc. Nephrol. 10: 822-832.
26. Tsukahara, H. 2007. Biomarkers for oxidative stress: clinical application in pediatric medicine. Curr. Med. Chem. 14: 339-351.
27. Thuraisingham, R. C., Nott, C. A., Dodd, S. M., and Yaqoob, M. M. 2000. Increased nitrotyrosine staining in kidneys from patients with diabetic nephropathy. Kidney Int. 57: 1968-1972.
28. Trachtman, H., Del-Pizzo, R., Futterweit, S., Levine, D., Rao, P. S., Valderrama, E., and Sturman, J. A. 1992. Taurine attenuates renal disease in chronic puromycin aminonucleoside nephropathy. Am. J. Physiol. 262: F117-123.
29. Trachtman, H., Futterweit, S., Maesaka, J., Ma, C., Valderrama, E., Fuchs, A., Tarectecan, A. A., Rao, P. S., Sturman, J. A., Boles, T. H., Fu, M. X., and Baynes, J. 1995. Taurine ameliorates chronic streptozocin-induced diabetic nephropathy in rats. Am. J. Physiol. 269: F429-438.
30. Uchida, S., Nakanishi, T., Kwon, H. M., Preston, A. S., and Handler, J. S. 1991. Taurine behaves as an osmolyte in Madin-Darby canine kidney cells. Protection by polarized, regulated transport of taurine. J. Clin. Invest. 88: 656-662.
31. Ueda, H., Ikegami, H., Yamato, E., Fu, J., Fukuda, M., Shen, G., Kawaguchi, Y., Takekawa, K., Fujioka, Y., Fujisawa, T., Nakagawa, Y., Hamada, Y., Shibata, M., and Ogihara, T. 1995. The NSY mouse: a new animal model of spontaneous NIDDM with moderate obesity. Diabetologia 38: 503-508.
32. Wu, Q. D., Wang, J. H., Fennessy, F., Redmond, H. P., and Bouchier-Hayes, D. 1999. Taurine prevents high-glucose-induced human vascular endothelial cell apoptosis. Am. J. Physiol. 277: C1229-1238.
33. You, J. S., and Chang, K. J. 1998. Effects of taurine supplementation on lipid peroxidation, blood glucose and blood lipid metabolism in streptozotocin-induced diabetic rats. Adv. Exp. Med. Biol. 442: 163-168.